Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A1 | P46059 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.31 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.31 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | FDPS | P14324 | 1/20 | 0.30 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.30 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.30 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.30 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22504504 | 1.00 | SLC15A1 (0.32) | SLC15A1ALDH1A1CTSKDPP4DPP8 | |
| SCHEMBL25462335 | 0.82 | CTSK (0.36) | SLC15A1ALDH1A1CTSKDPP4DPP8 | |
| SCHEMBL22854039 | 0.82 | LMNA (0.34) | — | |
| SCHEMBL20221623 | 0.80 | — | — | |
| SCHEMBL23872243 | 0.79 | CTSK (0.32) | CTSKDPP4DPP8DPP9DPP7 | |
| SCHEMBL14403147 | 0.78 | ALDH1A1 (0.33) | ALDH1A1CA1CA2CYP3A4TSHR | |
| SCHEMBL26047014 | 0.78 | TSHR (0.30) | TSHR | |
| SCHEMBL24728862 | 0.77 | — | — | |
| SCHEMBL20235701 | 0.76 | OPRM1 (0.35) | CTSKCA1FDPS | |
| SCHEMBL25777668 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230201248-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | SYNEDGEN, INC. | 2023-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230201248-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | ENGASE, FUT5, ALG1 | SLC15A1 3063/4885ALDH1A1 2639/4885CTSK 1301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.